Week of September 6, 2022 | Vol. 11, Issue 36

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates



Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health


Contact Information

Xan Smith

Managing Director

Business Development

xsmith@bourne-partners.com


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory

jjohnson@bourne-partners.com

Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners
September 22-23, 2022 - New Brunswick, NJ
October 12, 2022 - Charlotte, NC
October 24-26, 2022 - Leipzig, Germany
November 1-3, 2022 - Messe Frankfurt, Germany
INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
M&A TRANSACTIONS

Pharma & Biotech

7 transactions totaling $1,379 million


Supplies, Equipment & Services

15 transactions totaling $8,074 million


Healthcare IT & Managed Care

8 transaction



Healthcare Facilities & Distributors

4 transactions totaling $500 million

PRIVATE PLACEMENTS

Pharma & Biotech

22 transactions totaling $365 million


Supplies, Equipment & Services

21 transactions totaling $260 million


Healthcare IT & Managed Care

19 transactions totaling $215 million


Healthcare Facilities & Distributors

3 transactions totaling $96 million

PUBLIC OFFERINGS

Pharma & Biotech

15 transactions totaling $762 million


Supplies, Equipment & Services

3 transactions


Healthcare IT & Managed Care

1 transaction


Healthcare Facilities & Distributors

0 transactions

TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.






MARKET REPORTS
Insight Into Healthcare Related Industries

1H 2022 Pharma Services Sector Snapshot

August 2022

M&A PIPELINE
Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Sell-Side |Pharma Services| Clinical Trial Services Provider


Project Ester

Sell-side |Pharma| OTC Technology and Products Developer


Project Gateway

Sell-Side |Pharma| Generic Pharmaceuticals


Project Jazz

Sell-Side |Pharma Services| Compounding Pharmacy and Lab Testing Business

Project Panther

Sell-Side| CDMO | Consumer Health and Medical Device


Project Power Play

Buy-Side | Specialty Pharma |Branded & Generic Pharmaceuticals


Project S

Sell-side |Pharma Services | Compounding Pharmacy and Telehealth Platform


Project Trident

Buy-Side | Generic Pharma | Manufacturing liquid generics

FEATURED HEADLINES

A Sampling of Industry Headlines

InCarda, PhysIQ and Syneos team for phase 3 flecainide study

Fierce Biotech - August 31, 2022

LumaBridge inks deal with PICI to expand immunotherapy development

Fierce Biotech - August 31, 2022

Novo Nordisk to Acquire Forma Therapeutics for $1.1B

Contract Pharma - September 1, 2022

Cambrex Completes First Expansion Phase at Small Molecule API Mfg. Facility in NC

Contract Pharma - September 1, 2022

Cytovance Signs Service Agreement with GT Biopharma

Contract Pharma - September 2, 2022

Horizon Therapeutics to Expand Biologics Facility

Contract Phama - September 2, 2022

TANNER NEWS

Linkedin  

Rare Rev-inar September 22, 2022

Rare Revolution Magazine and Tanner Pharma are co-hosting a live webinar to discuss early access pathways, with insights from stakeholders across the spectrum. Register for the virtual event here.

Building a global supply chain network for clinical trial products

On-time deliveries are paramount in the pharma world, and navigating global supply chain challenges for clinical trials requires both meticulous planning and flexibility to quickly adapt to changing circumstances. Learn about Tanner's approach. 

Let's Connect!
The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.